Drug intelligence / Profile preview

geniposidic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Geniposidic acid is a natural iridoid glucoside found in various medicinal plants, including *Eucommia ulmoides* (Tochu) and *Gardenia jasminoides*. It exhibits a wide range of pharmacological activities, including anti-inflammatory, antioxidant, hepatoprotective, antihypertensive, and antifibrotic effects. Mechanistically, geniposidic acid acts as an agonist of the glucagon-like peptide-1 receptor (GLP-1R), which stimulates the secretion of atrial natriuretic peptide (ANP) to lower blood pressure. It also functions as a farnesoid X receptor (FXR) modulator and sirtuin 6 (SIRT6) activator, regulating bile acid and cholesterol metabolism, which contributes to its protective effects against drug-induced liver injury (DILI) and metabolic dysfunction-associated steatotic liver disease (MASLD). Additionally, geniposidic acid has been shown to suppress hepatic stellate cell (HSC) activation via modulation of the AKT/GSK-3β signaling pathway, highlighting its potential as an antifibrotic therapeutic.

Other names
GEAGPAgeniposidic acid
02

Targets

FXR (Farnesoid x-activated receptor)GLP1R (GLP-1R)SIRT6 (Sirtuin 6)

Beyond the preview

Go deeper on geniposidic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on geniposidic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call